Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1

Insulin resistance in skeletal muscle is found in obesity and type 2 diabetes. A mechanism for impaired insulin signaling in peripheral tissues is the inhibition of insulin action through serine phosphorylation of insulin receptor substrate (Irs) proteins that abolish the coupling of Irs proteins to...

Full description

Saved in:
Bibliographic Details
Published inThe FASEB journal Vol. 20; no. 8; pp. 1206 - 1208
Main Authors Hennige, Anita M, Stefan, Norbert, Kapp, Katja, Lehmann, Rainer, Weigert, Cora, Beck, Alexander, Moeschel, Klaus, Mushack, Joanne, Schleicher, Erwin, Häring, Hans-Ulrich
Format Journal Article
LanguageEnglish
Published United States The Federation of American Societies for Experimental Biology 01.06.2006
Subjects
Online AccessGet more information
ISSN0892-6638
1530-6860
DOI10.1096/fj.05-4635fje

Cover

Loading…
Abstract Insulin resistance in skeletal muscle is found in obesity and type 2 diabetes. A mechanism for impaired insulin signaling in peripheral tissues is the inhibition of insulin action through serine phosphorylation of insulin receptor substrate (Irs) proteins that abolish the coupling of Irs proteins to the activated insulin receptor. Recently, we described serine-318 as a protein kinase C (PKC)-dependent phosphorylation site in Irs1 (Ser-318) activated by hyperinsulinemia. Here we show in various cell models that the adipose hormone leptin, a putative mediator in obesity-related insulin resistance, promotes phosphorylation of Ser-318 in Irs1 by a janus kinase 2, Irs2, and PKC-dependent pathway. Mutation of Ser-318 to alanine abrogates the inhibitory effect of leptin on insulin-induced Irs1 tyrosine phosphorylation and glucose uptake in L6 myoblasts. In C57Bl/6 mice, Ser-318 phosphorylation levels in muscle tissue were enhanced by leptin and insulin administration in lean animals while in diet-induced obesity Ser-318 phosphorylation levels were already up-regulated in the basal state, and further stimulation was diminished. In analogy, in lymphocytes of obese hyperleptinemic human subjects basal Ser-318 phosphorylation levels were increased compared to lean individuals. During a hyperinsulinemic euglycemic clamp, the increment in Ser-318 phosphorylation observed in lean individuals was absent in obese. In summary, these data suggest that phosphorylation of Ser-318 in Irs1 mediates the inhibitory signal of leptin on the insulin-signaling cascade in obese subjects.--Hennige A. M., Stefan N., Kapp K., Lehmann R., Weigert C., Beck A., Moeschel K., Mushack J., Schleicher E., and Häring H. U. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1.
AbstractList Insulin resistance in skeletal muscle is found in obesity and type 2 diabetes. A mechanism for impaired insulin signaling in peripheral tissues is the inhibition of insulin action through serine phosphorylation of insulin receptor substrate (Irs) proteins that abolish the coupling of Irs proteins to the activated insulin receptor. Recently, we described serine-318 as a protein kinase C (PKC)-dependent phosphorylation site in Irs1 (Ser-318) activated by hyperinsulinemia. Here we show in various cell models that the adipose hormone leptin, a putative mediator in obesity-related insulin resistance, promotes phosphorylation of Ser-318 in Irs1 by a janus kinase 2, Irs2, and PKC-dependent pathway. Mutation of Ser-318 to alanine abrogates the inhibitory effect of leptin on insulin-induced Irs1 tyrosine phosphorylation and glucose uptake in L6 myoblasts. In C57Bl/6 mice, Ser-318 phosphorylation levels in muscle tissue were enhanced by leptin and insulin administration in lean animals while in diet-induced obesity Ser-318 phosphorylation levels were already up-regulated in the basal state, and further stimulation was diminished. In analogy, in lymphocytes of obese hyperleptinemic human subjects basal Ser-318 phosphorylation levels were increased compared to lean individuals. During a hyperinsulinemic euglycemic clamp, the increment in Ser-318 phosphorylation observed in lean individuals was absent in obese. In summary, these data suggest that phosphorylation of Ser-318 in Irs1 mediates the inhibitory signal of leptin on the insulin-signaling cascade in obese subjects.
Insulin resistance in skeletal muscle is found in obesity and type 2 diabetes. A mechanism for impaired insulin signaling in peripheral tissues is the inhibition of insulin action through serine phosphorylation of insulin receptor substrate (Irs) proteins that abolish the coupling of Irs proteins to the activated insulin receptor. Recently, we described serine-318 as a protein kinase C (PKC)-dependent phosphorylation site in Irs1 (Ser-318) activated by hyperinsulinemia. Here we show in various cell models that the adipose hormone leptin, a putative mediator in obesity-related insulin resistance, promotes phosphorylation of Ser-318 in Irs1 by a janus kinase 2, Irs2, and PKC-dependent pathway. Mutation of Ser-318 to alanine abrogates the inhibitory effect of leptin on insulin-induced Irs1 tyrosine phosphorylation and glucose uptake in L6 myoblasts. In C57Bl/6 mice, Ser-318 phosphorylation levels in muscle tissue were enhanced by leptin and insulin administration in lean animals while in diet-induced obesity Ser-318 phosphorylation levels were already up-regulated in the basal state, and further stimulation was diminished. In analogy, in lymphocytes of obese hyperleptinemic human subjects basal Ser-318 phosphorylation levels were increased compared to lean individuals. During a hyperinsulinemic euglycemic clamp, the increment in Ser-318 phosphorylation observed in lean individuals was absent in obese. In summary, these data suggest that phosphorylation of Ser-318 in Irs1 mediates the inhibitory signal of leptin on the insulin-signaling cascade in obese subjects.--Hennige A. M., Stefan N., Kapp K., Lehmann R., Weigert C., Beck A., Moeschel K., Mushack J., Schleicher E., and Häring H. U. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1.
Author Moeschel, Klaus
Weigert, Cora
Hennige, Anita M
Lehmann, Rainer
Beck, Alexander
Schleicher, Erwin
Stefan, Norbert
Häring, Hans-Ulrich
Mushack, Joanne
Kapp, Katja
Author_xml – sequence: 1
  fullname: Hennige, Anita M
– sequence: 2
  fullname: Stefan, Norbert
– sequence: 3
  fullname: Kapp, Katja
– sequence: 4
  fullname: Lehmann, Rainer
– sequence: 5
  fullname: Weigert, Cora
– sequence: 6
  fullname: Beck, Alexander
– sequence: 7
  fullname: Moeschel, Klaus
– sequence: 8
  fullname: Mushack, Joanne
– sequence: 9
  fullname: Schleicher, Erwin
– sequence: 10
  fullname: Häring, Hans-Ulrich
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16611834$$D View this record in MEDLINE/PubMed
BookMark eNo9kMtKAzEUhoMo9qJLt5oXSM1lkkmWUuoFCi606yGZnrQztJMhmUH69kaqLg4Hfr7_g3Nm6LILHSB0x-iCUaMefbugkhRKSN_CBZoyKShRWtFLNKXacKKU0BM0S6mllDLK1DWaMKUY06KYonYN_dB0eBu-OhJhNx7sAAk3XRoPObb10IQOD_sYxt0e9_uQ8sRTpn7y4HGC2HRABNO59N-LUGdviDiNLg0xOzG7QVfeHhLc_u452jyvPpevZP3-8rZ8WpNaqmJFoLQaSl977xkrROlkyYFKV3jmaGGsVEZ6qTl3oA0tlDPAvTa2BKe3wGo-R_dnbz-6I2yrPjZHG0_V39EZeDgD3obK7mKTqs0Hp0zk95RGl4J_AyK3Zmk
CitedBy_id crossref_primary_10_1007_s00394_009_0052_8
crossref_primary_10_3724_SP_J_1008_2010_01123
crossref_primary_10_1074_jbc_M114_554162
crossref_primary_10_1007_s00125_010_1668_1
crossref_primary_10_1152_ajpregu_00133_2007
crossref_primary_10_1016_j_mce_2007_12_013
crossref_primary_10_1152_ajpcell_00595_2020
crossref_primary_10_1186_1475_2840_9_46
crossref_primary_10_1016_j_febslet_2007_06_044
crossref_primary_10_1210_me_2008_0102
crossref_primary_10_1016_j_bbadis_2008_10_019
crossref_primary_10_1074_jbc_M708588200
crossref_primary_10_1055_s_0040_1712830
crossref_primary_10_1210_en_2007_1355
crossref_primary_10_1002_dmrr_881
crossref_primary_10_3390_ijms241914678
crossref_primary_10_1371_journal_pone_0013959
crossref_primary_10_1016_j_ijcard_2007_11_058
crossref_primary_10_1210_en_2014_1094
crossref_primary_10_1016_j_ejphar_2013_06_023
crossref_primary_10_1016_j_jnutbio_2012_08_009
crossref_primary_10_1210_er_2007_0006
crossref_primary_10_1016_j_atherosclerosis_2008_09_021
crossref_primary_10_1002_mrd_22029
crossref_primary_10_1111_j_1582_4934_2008_00629_x
crossref_primary_10_1210_jc_2009_0469
crossref_primary_10_1007_BF03346702
crossref_primary_10_1186_ar3874
crossref_primary_10_3389_fendo_2023_1265719
crossref_primary_10_1007_s00125_009_1522_5
crossref_primary_10_1164_rccm_201009_1409OC
crossref_primary_10_1097_SMJ_0b013e3181cf373f
crossref_primary_10_1016_j_molmet_2021_101236
crossref_primary_10_1093_sleep_34_2_153
crossref_primary_10_1002_jcb_22331
crossref_primary_10_3390_ijms23116279
crossref_primary_10_1002_rmb2_12575
crossref_primary_10_1152_ajpendo_90437_2008
crossref_primary_10_1016_j_gene_2016_05_018
crossref_primary_10_1073_pnas_0809743105
crossref_primary_10_1016_j_mehy_2006_10_053
crossref_primary_10_1016_j_ejmech_2012_02_012
crossref_primary_10_1016_j_phrs_2008_12_002
crossref_primary_10_1097_MED_0b013e32802e6d87
crossref_primary_10_1016_j_mce_2011_12_017
crossref_primary_10_1111_hel_12537
crossref_primary_10_1152_ajpendo_90491_2008
crossref_primary_10_1016_j_ajg_2011_04_008
crossref_primary_10_1016_j_clml_2017_05_004
crossref_primary_10_1097_CEJ_0b013e328338f7d2
crossref_primary_10_1007_s00125_012_2644_8
crossref_primary_10_1080_10715760903196925
crossref_primary_10_1152_physiolgenomics_00057_2011
crossref_primary_10_3109_08037051_2014_901021
crossref_primary_10_1080_22201009_2012_10872280
crossref_primary_10_1038_sj_bmt_1705972
crossref_primary_10_1016_j_numecd_2011_03_009
crossref_primary_10_1016_S1734_1140_09_70038_6
crossref_primary_10_1161_CIRCULATIONAHA_107_741645
crossref_primary_10_5507_bp_2014_036
crossref_primary_10_1016_j_mad_2012_03_006
crossref_primary_10_3390_biomedicines8070182
crossref_primary_10_1007_s11684_013_0288_9
crossref_primary_10_3389_fmicb_2017_00743
crossref_primary_10_1016_j_bcmd_2007_08_009
crossref_primary_10_1194_jlr_M019687
ContentType Journal Article
DBID FBQ
CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1096/fj.05-4635fje
DatabaseName AGRIS
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1530-6860
EndPage 1208
ExternalDocumentID 16611834
US201301079873
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-~X
.55
0R~
0VX
123
18M
1OB
1OC
29H
2WC
33P
34G
39C
3O-
4.4
53G
5GY
5RE
85S
AAHHS
AANLZ
ABCUV
ABDNZ
ABEFU
ABJNI
ABOCM
ABPTK
ACCFJ
ACCZN
ACGFS
ACIWK
ACNCT
ACPOU
ACPRK
ACXQS
ACYGS
ADKYN
ADZMN
AEEZP
AEIGN
AENEX
AEQDE
AEQTP
AEUYR
AFDAS
AFFNX
AFFPM
AFMIJ
AFRAH
AGCDD
AI.
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
BFHJK
C1A
CS3
DCZOG
DU5
D~5
E3Z
EBS
EJD
F20
F5P
F9R
FBQ
FRP
HZ~
H~9
J5H
L7B
LATKE
LEEKS
MEWTI
MVM
NEJ
O9-
OHT
OVD
Q-A
RHF
RHI
RJQFR
ROL
SAMSI
SJN
SUPJJ
TEORI
TFA
TR2
TWZ
VH1
W8F
WH7
WHG
WOQ
WXSBR
X7M
XJT
XOL
XSW
Y6R
YBU
YCJ
YHG
YKV
YNH
YSK
Z0Y
ZA5
ZCA
ZE2
ZGI
ZXP
~KM
AAHQN
AAMNL
AAYCA
AFWVQ
AHBTC
AITYG
AIZAD
ALVPJ
BIYOS
CGR
CUY
CVF
ECM
EIF
H13
HGLYW
NPM
U18
VXZ
Z5M
ID FETCH-LOGICAL-c564E-e7a8e7fcfff11437b572e05b4f1b049a5695f5822be89046b9e2f89a7eb8de1c2
ISSN 0892-6638
IngestDate Wed Feb 19 01:49:04 EST 2025
Wed Dec 27 19:11:19 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c564E-e7a8e7fcfff11437b572e05b4f1b049a5695f5822be89046b9e2f89a7eb8de1c2
Notes http://www.fasebj.org/
PMID 16611834
PageCount 3
ParticipantIDs pubmed_primary_16611834
fao_agris_US201301079873
PublicationCentury 2000
PublicationDate June 2006
PublicationDateYYYYMMDD 2006-06-01
PublicationDate_xml – month: 06
  year: 2006
  text: June 2006
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The FASEB journal
PublicationTitleAlternate FASEB J
PublicationYear 2006
Publisher The Federation of American Societies for Experimental Biology
Publisher_xml – name: The Federation of American Societies for Experimental Biology
SSID ssj0001016
Score 2.1511476
Snippet Insulin resistance in skeletal muscle is found in obesity and type 2 diabetes. A mechanism for impaired insulin signaling in peripheral tissues is the...
SourceID pubmed
fao
SourceType Index Database
Publisher
StartPage 1206
SubjectTerms Adult
Animals
Biological Transport - drug effects
Deoxyglucose - metabolism
Down-Regulation
Female
Humans
Insulin - pharmacology
Insulin Antagonists - pharmacology
Insulin Receptor Substrate Proteins
Isoenzymes - metabolism
Janus Kinase 2
Leptin - pharmacology
Lymphocytes - enzymology
Male
Mice
Mice, Inbred C57BL
Middle Aged
Muscle, Skeletal - enzymology
Obesity - enzymology
Phosphoproteins - chemistry
Phosphoproteins - metabolism
Phosphorylation
Protein Kinase C-delta - metabolism
Protein-Tyrosine Kinases - metabolism
Proto-Oncogene Proteins - metabolism
Serine - metabolism
Title Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1
URI https://www.ncbi.nlm.nih.gov/pubmed/16611834
Volume 20
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEBZOSqGXkj7zaIsOvRml-5C00tEJDqEkpiUx5GakXamJSXeNnR6af9Z_19FKK69DCm0PK9YLErLm45sZaTSD0EchVUlNlRBRVRWhKtFEpbokOeO55rZIWeUcxfMJP53Sz1fsajD41Yta-nGnD8v7R--V_I9U4RvI1d2S_QfJxkHhA7yDfKEFCUP7VzI-cyEp9bACT5osfVH5Nr7Kh5eHKuBdJZ7FdbOCZ_nzNlqJq_bun7va7LY9un7AgTBusxyugFTa5LXDtG_DOmSdjC7GR8P-JP2Fh_rGl2ofAVOofq1iY_1O66RZulDuyPNqsQhBHfOoIM7M9fdQu9kdP4X44d7WBO9vTbTTcSkx4t-Kp1A-JPXGtDknQlbnUMzA1-Dc4EGZETCMPE2bjqfB6xW-FEFH5FnSA6zosXKaJbyn4eGneFR7gDvnRD4_TBihYInZuVmryRi8OL3I3HEv-M1SFPkW2gIHxeUXPfoaTQC3JdK6L2HmIbkrjP9pY3QwaKxqHng0rWVzuYOeB5cEjzy-XqCBqV-ip2GBXqG5RxneRBkOaMEeZTigDD9AGW4sXqMMOsV-HcpwRBlOX6Ppyfjy-JSECh2kZJyOiSmUMIUtrbXgV-eFZkVmEqapTTW4nopxySwDG1QbIRPKtTSZBXoojBaVScvsDdqum9rsIuwkanhqq8IW1C1tLq2yMsuUlEpYuod2Yalm6hvovtmmCPbQW79-s4XP0DJLweoEXUX3_9zpAD1bQ_YdemKBE8x7MDDv9IdWmNBOvpz_Bh9Uf6s
linkProvider FAO Food and Agriculture Organization of the United Nations
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Leptin+down-regulates+insulin+action+through+phosphorylation+of+serine-318+in+insulin+receptor+substrate+1&rft.jtitle=The+FASEB+journal&rft.au=Hennige%2C+Anita+M&rft.au=Stefan%2C+Norbert&rft.au=Kapp%2C+Katja&rft.au=Lehmann%2C+Rainer&rft.date=2006-06-01&rft.pub=The+Federation+of+American+Societies+for+Experimental+Biology&rft.issn=0892-6638&rft.eissn=1530-6860&rft.volume=20&rft.issue=8&rft.spage=1206&rft.epage=1208&rft_id=info:doi/10.1096%2Ffj.05-4635fje&rft.externalDocID=US201301079873
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-6638&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-6638&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-6638&client=summon